NCT03744312View on ClinicalTrials.gov

Imaging Inflammation in Alzheimer's Disease With 11C-ER176

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 10, 2018

Primary Completion Date

July 20, 2022

Study Completion Date

July 20, 2022

Conditions
Alzheimer Disease
Interventions
DRUG

11C-ER176

11C-ER176 sticks to parts of the brain where there is inflammation. Past studies have shown that inflammation is present in the brains of patients with Alzheimer's disease. The purpose of this study is to determine if 11C-ER176 is able to accurately measure inflammation in patients with Alzheimer's disease.

DRUG

Florbetaben

Florbetaben sticks to amyloid plaques, which are in the brain in Alzheimer's disease.

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT03744312 - Imaging Inflammation in Alzheimer's Disease With 11C-ER176 | Biotech Hunter | Biotech Hunter